Sun Pharmaceutical Industries Ltd. | Large-cap | Healthcare
₹1,669.80
0.01%
| Sun Pharmaceutical Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 520.4B
Gross Profit 412.9B 79.35%
Operating Income 125.1B 24.04%
Net Income 109.6B 21.07%
EPS (Diluted) ₹45.60

Balance Sheet Metrics

Total Assets 921.0B
Total Liabilities 196.1B
Shareholders Equity 724.9B
Debt to Equity 0.27

Cash Flow Metrics

Operating Cash Flow 110.8B
Free Cash Flow 119.4B

Revenue & Profitability Trend

Sun Pharmaceutical Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 520.4B 477.6B 432.8B 384.3B 332.3B
Cost of Goods Sold 107.5B 120.7B 119.4B 103.5B 98.9B
Gross Profit 412.9B 356.9B 313.4B 280.7B 233.5B
Operating Expenses 167.7B 139.0B 117.8B 162.3B 82.2B
Operating Income 125.1B 104.7B 92.8B 81.0B 64.1B
Pre-tax Income 137.5B 110.9B 94.1B 44.8B 28.0B
Income Tax 26.3B 14.4B 8.5B 10.8B 5.1B
Net Income 109.6B 96.1B 85.1B 33.9B 22.7B
EPS (Diluted) ₹45.60 ₹39.90 ₹35.30 ₹13.60 ₹12.10

Income Statement Trend

Sun Pharmaceutical Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 526.2B 434.7B 398.8B 350.1B 304.4B
Non-Current Assets 394.8B 419.9B 408.6B 347.8B 372.2B
Total Assets 921.0B 854.6B 807.4B 698.0B 676.7B
Liabilities
Current Liabilities 181.9B 169.8B 199.1B 172.0B 161.5B
Non-Current Liabilities 14.2B 13.7B 15.2B 15.3B 20.4B
Total Liabilities 196.1B 183.6B 214.3B 187.3B 181.9B
Equity
Total Shareholders Equity 724.9B 671.1B 593.2B 510.7B 494.8B

Balance Sheet Composition

Sun Pharmaceutical Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 137.5B 110.9B 94.1B 44.8B 28.0B
Operating Cash Flow 110.8B 110.8B 61.4B 6.9B 43.5B
Investing Activities
Capital Expenditures -20.7B -21.7B -20.6B -14.3B -10.7B
Investing Cash Flow -62.0B -13.8B -83.9B -59.4B 2.4B
Financing Activities
Dividends Paid -36.1B -29.0B -25.2B -21.6B -15.6B
Financing Cash Flow -75.4B -63.7B 26.1B -49.8B -56.9B
Free Cash Flow 119.4B 99.3B 28.7B 74.9B 50.0B

Cash Flow Trend

Sun Pharmaceutical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 36.44
Forward P/E 50.87
Price to Book 5.50
Price to Sales 7.59
PEG Ratio 50.87

Profitability Ratios

Profit Margin 20.79%
Operating Margin 21.31%
Return on Equity 15.71%
Return on Assets 8.81%

Financial Health

Current Ratio 2.89
Debt to Equity 3.26
Beta 0.38

Per Share Data

EPS (TTM) ₹45.62
Book Value per Share ₹302.33
Revenue per Share ₹219.38

Financial data is updated regularly. All figures are in the company's reporting currency.